PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
BSX vs. STE
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


BSXSTE
YTD Return24.91%-6.53%
1Y Return36.50%8.91%
3Y Return (Ann)18.34%-0.06%
5Y Return (Ann)14.22%10.03%
10Y Return (Ann)18.91%16.96%
Sharpe Ratio1.830.35
Daily Std Dev20.10%21.87%
Max Drawdown-89.15%-77.21%
Current Drawdown-1.43%-17.36%

Fundamentals


BSXSTE
Market Cap$107.55B$20.15B
EPS$1.19$5.69
PE Ratio61.4935.83
PEG Ratio1.806.88
Revenue (TTM)$14.71B$5.41B
Gross Profit (TTM)$8.68B$2.16B
EBITDA (TTM)$3.74B$1.42B

Correlation

-0.50.00.51.00.3

The correlation between BSX and STE is 0.30, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

BSX vs. STE - Performance Comparison

In the year-to-date period, BSX achieves a 24.91% return, which is significantly higher than STE's -6.53% return. Over the past 10 years, BSX has outperformed STE with an annualized return of 18.91%, while STE has yielded a comparatively lower 16.96% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


0.00%5,000.00%10,000.00%15,000.00%December2024FebruaryMarchAprilMay
1,461.30%
13,334.67%
BSX
STE

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Boston Scientific Corporation

STERIS plc

Risk-Adjusted Performance

BSX vs. STE - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Boston Scientific Corporation (BSX) and STERIS plc (STE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


BSX
Sharpe ratio
The chart of Sharpe ratio for BSX, currently valued at 1.83, compared to the broader market-2.00-1.000.001.002.003.004.001.83
Sortino ratio
The chart of Sortino ratio for BSX, currently valued at 2.64, compared to the broader market-4.00-2.000.002.004.006.002.64
Omega ratio
The chart of Omega ratio for BSX, currently valued at 1.36, compared to the broader market0.501.001.501.36
Calmar ratio
The chart of Calmar ratio for BSX, currently valued at 3.33, compared to the broader market0.002.004.006.003.33
Martin ratio
The chart of Martin ratio for BSX, currently valued at 10.31, compared to the broader market-10.000.0010.0020.0030.0010.31
STE
Sharpe ratio
The chart of Sharpe ratio for STE, currently valued at 0.35, compared to the broader market-2.00-1.000.001.002.003.004.000.35
Sortino ratio
The chart of Sortino ratio for STE, currently valued at 0.68, compared to the broader market-4.00-2.000.002.004.006.000.68
Omega ratio
The chart of Omega ratio for STE, currently valued at 1.08, compared to the broader market0.501.001.501.08
Calmar ratio
The chart of Calmar ratio for STE, currently valued at 0.31, compared to the broader market0.002.004.006.000.31
Martin ratio
The chart of Martin ratio for STE, currently valued at 1.15, compared to the broader market-10.000.0010.0020.0030.001.15

BSX vs. STE - Sharpe Ratio Comparison

The current BSX Sharpe Ratio is 1.83, which is higher than the STE Sharpe Ratio of 0.35. The chart below compares the 12-month rolling Sharpe Ratio of BSX and STE.


Rolling 12-month Sharpe Ratio0.000.501.001.502.00December2024FebruaryMarchAprilMay
1.83
0.35
BSX
STE

Dividends

BSX vs. STE - Dividend Comparison

BSX has not paid dividends to shareholders, while STE's dividend yield for the trailing twelve months is around 0.99%.


TTM20232022202120202019201820172016201520142013
BSX
Boston Scientific Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
STE
STERIS plc
0.99%0.90%0.97%0.68%0.81%0.93%1.22%1.35%1.57%1.27%1.36%1.66%

Drawdowns

BSX vs. STE - Drawdown Comparison

The maximum BSX drawdown since its inception was -89.15%, which is greater than STE's maximum drawdown of -77.21%. Use the drawdown chart below to compare losses from any high point for BSX and STE. For additional features, visit the drawdowns tool.


-20.00%-15.00%-10.00%-5.00%0.00%December2024FebruaryMarchAprilMay
-1.43%
-17.36%
BSX
STE

Volatility

BSX vs. STE - Volatility Comparison

Boston Scientific Corporation (BSX) has a higher volatility of 6.49% compared to STERIS plc (STE) at 5.40%. This indicates that BSX's price experiences larger fluctuations and is considered to be riskier than STE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


3.00%4.00%5.00%6.00%7.00%8.00%9.00%December2024FebruaryMarchAprilMay
6.49%
5.40%
BSX
STE

Financials

BSX vs. STE - Financials Comparison

This section allows you to compare key financial metrics between Boston Scientific Corporation and STERIS plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items